Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
2021 · Frontiers in Cardiovascular Medicine · 14 citations
https://doi.org/10.3389/fcvm.2021.752468
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
141
Citations
7
h-index
7
i10-index
Shih‐Wei Wang is an academic researcher from Mackay Medical University. The author has contributed to research in topics: Bone health and treatments & Bone health and osteoporosis research & Lipoproteins and Cardiovascular Health. The author has an h-index of 7, co-authored 13 publications.
ORCID: 0000-0003-3314-4871Click to start Chat